ATE469920T1 - Herstellung von rekombinanten igm in den per.c6 zellen - Google Patents

Herstellung von rekombinanten igm in den per.c6 zellen

Info

Publication number
ATE469920T1
ATE469920T1 AT04741596T AT04741596T ATE469920T1 AT E469920 T1 ATE469920 T1 AT E469920T1 AT 04741596 T AT04741596 T AT 04741596T AT 04741596 T AT04741596 T AT 04741596T AT E469920 T1 ATE469920 T1 AT E469920T1
Authority
AT
Austria
Prior art keywords
production
igm
cells
per
recombinant igm
Prior art date
Application number
AT04741596T
Other languages
English (en)
Inventor
David Jones
Original Assignee
Crucell Holland Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crucell Holland Bv filed Critical Crucell Holland Bv
Application granted granted Critical
Publication of ATE469920T1 publication Critical patent/ATE469920T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT04741596T 2003-05-23 2004-05-18 Herstellung von rekombinanten igm in den per.c6 zellen ATE469920T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP0350194 2003-05-23
PCT/EP2004/050844 WO2004104046A1 (en) 2003-05-23 2004-05-18 Production of recombinant igm in per.c6 cells

Publications (1)

Publication Number Publication Date
ATE469920T1 true ATE469920T1 (de) 2010-06-15

Family

ID=33462066

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04741596T ATE469920T1 (de) 2003-05-23 2004-05-18 Herstellung von rekombinanten igm in den per.c6 zellen

Country Status (8)

Country Link
US (1) US20060063234A1 (de)
EP (1) EP1626992B1 (de)
AT (1) ATE469920T1 (de)
AU (1) AU2004240782B2 (de)
CA (1) CA2521490C (de)
DE (1) DE602004027483D1 (de)
DK (1) DK1626992T3 (de)
WO (1) WO2004104046A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658924B2 (en) * 2001-10-11 2010-02-09 Amgen Inc. Angiopoietin-2 specific binding agents
JO2913B1 (en) * 2008-02-20 2015-09-15 امجين إنك, Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
JP2014105159A (ja) * 2012-11-22 2014-06-09 Nippon Koden Corp ヒト由来上皮細胞接着分子に対するモノクローナル抗体、およびこれを用いた循環腫瘍細胞の検出方法
KR102306492B1 (ko) 2013-09-05 2021-09-29 아이쥐엠 바이오사이언스 인코포레이티드 불변 쇄 변형된 이특이적, 5가 및 6가 ig-m 항체
EP3560954B1 (de) 2014-04-03 2021-08-04 IGM Biosciences, Inc. Modifizierte j-kette
BR112017018941B8 (pt) 2015-03-04 2023-01-10 Igm Biosciences Inc Molécula de ligação a cd20, seu uso, composição e método in vitro para direcionar a morte mediada por complemento de uma célula que expressa cd20
CN108463245A (zh) 2015-09-30 2018-08-28 Igm生物科学有限公司 具有修饰的j链的结合分子
EP3356401B1 (de) 2015-09-30 2020-06-24 IGM Biosciences, Inc. Bindungsmoleküle mit modifizierter j-kette

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4835260A (en) * 1987-03-20 1989-05-30 Genetics Institute, Inc. Erythropoietin composition
GB8719963D0 (en) * 1987-08-24 1987-09-30 Cattaneo A Recombinant dna products
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
US5047335A (en) * 1988-12-21 1991-09-10 The Regents Of The University Of Calif. Process for controlling intracellular glycosylation of proteins
GB8900483D0 (en) * 1989-01-10 1989-03-08 Celltech Ltd Recombinant dna method
DE3923963A1 (de) * 1989-07-20 1991-01-31 Behringwerke Ag Muteine des menschlichen erythropoetins, ihre herstellung und ihre verwendung
US5856298A (en) * 1989-10-13 1999-01-05 Amgen Inc. Erythropoietin isoforms
US5384249A (en) * 1991-12-17 1995-01-24 Kyowa Hakko Kogyo Co., Ltd. α2→3 sialyltransferase
US5631158A (en) * 1993-10-25 1997-05-20 Creative Biomolecules, Inc. Methods and compositions for high protein production from non-native DNA
US5830851A (en) * 1993-11-19 1998-11-03 Affymax Technologies N.V. Methods of administering peptides that bind to the erythropoietin receptor
US5773569A (en) * 1993-11-19 1998-06-30 Affymax Technologies N.V. Compounds and peptides that bind to the erythropoietin receptor
US5789247A (en) * 1994-04-01 1998-08-04 Ballay; Annick Expression in non-tumoral human lymphoblastoid lines with an integrative vector
US5767078A (en) * 1995-06-07 1998-06-16 Johnson; Dana L. Agonist peptide dimers
SI0833934T2 (sl) * 1995-06-15 2013-04-30 Crucell Holland B.V. Pakirni sistemi za humani rekombinantni adenovirus za uporabo v genski terapiji
CA2235629A1 (en) * 1995-11-13 1997-05-22 Takara Shuzo Co., Ltd. Method for gene transfer into target cells with retrovirus
US5835382A (en) * 1996-04-26 1998-11-10 The Scripps Research Institute Small molecule mimetics of erythropoietin
WO1999066041A1 (en) * 1998-06-16 1999-12-23 Human Genome Sciences, Inc. 94 human secreted proteins
US6670188B1 (en) * 1998-04-24 2003-12-30 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
US6855544B1 (en) * 1999-04-15 2005-02-15 Crucell Holland B.V. Recombinant protein production in a human cell
ES2237420T5 (es) * 1999-04-15 2010-03-03 Crucell Holland B.V. Produccion de proteina recombinante en una celula humana.
US6492169B1 (en) * 1999-05-18 2002-12-10 Crucell Holland, B.V. Complementing cell lines
US6558948B1 (en) * 1999-11-23 2003-05-06 Stefan Kochanek Permanent amniocytic cell line, its production and use for the production of gene transfer vectors
ATE536375T1 (de) * 2000-05-10 2011-12-15 Mayo Foundation Menschliche igm antikörper, welche die fähigkeit besitzen, den wiederaufbau der myelinstruktur zu induzieren und deren diagnostische und therapeutische anwendung im zentralen nervensystem
US7151164B2 (en) * 2002-02-14 2006-12-19 Immunomedics, Inc. Anti-CD20 antibodies and fusion proteins thereof and methods of use
PT2314629E (pt) * 2002-07-18 2014-01-22 Merus B V Produção recombinante de misturas de anticorpos

Also Published As

Publication number Publication date
EP1626992B1 (de) 2010-06-02
AU2004240782B2 (en) 2011-04-21
AU2004240782A1 (en) 2004-12-02
CA2521490C (en) 2013-07-30
US20060063234A1 (en) 2006-03-23
WO2004104046A1 (en) 2004-12-02
EP1626992A1 (de) 2006-02-22
DK1626992T3 (da) 2010-09-20
CA2521490A1 (en) 2004-12-02
DE602004027483D1 (de) 2010-07-15

Similar Documents

Publication Publication Date Title
ATE412761T1 (de) Methode um rekombinante proteine in cho zellen zu exprimieren
ATE374827T1 (de) Überexpression von gewünschten proteinen in eukaryotischen zellen mittels überexpression von cyclin d1
ES2155702T4 (es) Construcciones expresivas halteroformes para la terapia genetica.
BRPI0514396A2 (pt) polipeptìdeos dependentes de vitamina k modificada
ATE500331T1 (de) Verfahren zur gleichzeitigen herstellung von multiplen proteinen; vektoren und zellen, die hierfür verwendung finden
ATE445704T1 (de) Expressionsvektor für tierische zellen
DK1007698T3 (da) Ekspression af heterologe proteiner
ATE374828T1 (de) Expressionsvektor zur antibiotikafreien expression
ATE338821T1 (de) Strukturprotein von aav, seine herstellung und verwendung
HUP0303843A2 (hu) CLyA-hemolizin alkalmazása proteinek exkretáltatására
ATE278024T1 (de) Methode zur herstellung von rekombinanten zellen
WO2005003315A3 (en) Compositions and methods for peptide-assisted transfection
ATE469920T1 (de) Herstellung von rekombinanten igm in den per.c6 zellen
AU3217100A (en) Methods of use of a novel lysyl oxidase-related protein
WO2003078576A3 (en) Vector for transfection of eukaryotic cells
DE60332993D1 (de) Das biomolekültransduktionsmotiv mph-1-btm und dessen verwendung
DK1082423T3 (da) Cyclin E2-gener og -proteiner
ATE321843T1 (de) Zellen, kulturverfahren, und ihre verwendung in autologer transplantationstherapie
EP1702071A4 (de) Transaktivierungssystem für säugerzellen
ATE513033T1 (de) Expression von proteinen in aus nabelschnurblut gewonnenen endothelzellen
ATE464320T1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
MY162658A (en) Genes encoding major capsid protein l1 of human papilloma virus and use of the same
AP2368A (en) Novel expression vectors and uses thereof.
WO2004065554A3 (en) Human saa3 nucleic acid molecule, protein, and methods of use for same
DE60011464D1 (de) Herstellung von heterloge proteine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1626992

Country of ref document: EP